Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.42 |
| ▸ | HTR3B | O95264 | 2/20 | 0.42 |
| ▸ | HTR3A | P46098 | 2/20 | 0.42 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.42 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2576555 | 0.86 | SIGMAR1 (0.40) | SIGMAR1CYP1A2ALDH1A1HTR3EHTR3B | |
| SCHEMBL5145155 | 0.81 | RAB9A (0.51) | SIGMAR1CYP1A2ALDH1A1TDP1MAOA | |
| SCHEMBL7751770 | 0.81 | CYP1A2 (0.50) | SIGMAR1CYP1A2ALDH1A1TDP1MAOA | |
| SCHEMBL69928 | 0.81 | CYP1A2 (0.50) | SIGMAR1CYP1A2ALDH1A1TDP1MAOA | |
| SCHEMBL6006369 | 0.78 | ALDH1A1 (0.44) | SIGMAR1CYP1A2ALDH1A1HTR3EHTR3B | |
| SCHEMBL49212 | 0.76 | ALDH1A1 (0.58) | SIGMAR1CYP1A2ALDH1A1TDP1MAOA | |
| SCHEMBL1056695 | 0.76 | ACHE (0.58) | SIGMAR1ALDH1A1HTR3EHTR3BHTR3A | |
| SCHEMBL28219746 | 0.75 | MEN1 (0.49) | SIGMAR1CYP1A2ALDH1A1TDP1MAOA | |
| SCHEMBL1903385 | 0.74 | HTR3E (0.52) | SIGMAR1ALDH1A1HTR3EHTR3BHTR3A | |
| SCHEMBL6422598 | 0.74 | CYP2A6 (0.54) | CYP1A2HTR3EHTR3BHTR3AHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8048541-B2 | Organic electroluminescence device | CITY UNIVERSITY OF HONG KONG (HK) | 2011-11-01 | — | — | US | disclosed |
| US-20100148662-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2010-06-17 | — | — | US | disclosed |
| US-7429662-B2 | Red-emitting electrophosphorescent devices | CITY UNIVERSITY OF HONG KONG (CN) | 2008-09-30 | — | — | US | disclosed |
| US-20060261730-A1 | Red-emitting electrophosphorescent devices | CITY UNIVERSITY OF HONG KONG (CN) | 2006-11-23 | — | — | US | disclosed |
| US-6861162-B2 | Doped thin films; multilayer; electrolytic cells; light emitting diodes | CITYU RESEARCH LTD. (CN) | 2005-03-01 | — | — | US | disclosed |
| US-6833202-B2 | Luminescent layer uses as salicylaldiminato Schiff bases or their metal complexes based on diaminomaleonitrile and salicylaldehyde derivatives as red-emitting materials; color chromaticity | CITY UNIVERSITY OF HONG KONG (CN) | 2004-12-21 | — | — | US | disclosed |
| US-20040180234-A1 | Electroluminescent devices | HONG KONG, CITY UNIVERSITY OF (CN) | 2004-09-16 | — | — | US | disclosed |
| US-20040043247-A1 | Organic electroluminescence devices using pyrazolo [3,4B] quinoxaline derivatives | INTELLECTUAL VENTURES HOLDING 57 LLC | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180234-A1 | Electroluminescent devices | SLC25A13, AOC1, DDT | SIGMAR1 4190/4885CYP1A2 2986/4885ALDH1A1 37/4885 |
| US-20100148662-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IK, CACNA2D3, CACNA2D4 | SIGMAR1 840/4885CYP1A2 2454/4885ALDH1A1 321/4885 |
| US-20060261730-A1 | Red-emitting electrophosphorescent devices | IK, EED, SPR | SIGMAR1 1889/4885CYP1A2 934/4885ALDH1A1 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.